H6D0:ETR
Haleon PLC
€4.50
arrow_upward
+0.04%(+0.0020) 1D
Oct 20, 5:35:33 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for H6D0...
Open
€4.54
High
€4.54
Low
€4.50
Mkt. cap
44.31B
Avg. vol.
20.12K
Volume
53.16K
52-wk high
€4.78
52-wk low
€3.72
No. of employees
25K
Open
€4.54
High
€4.54
Low
€4.50
Mkt. cap
44.31B
Avg. vol.
20.12K
Volume
53.16K
52-wk high
€4.78
52-wk low
€3.72
No. of employees
25K
News stories
From web sources and news partners
Proactive financial news
·
3 hours ago
UBS says early flu pick-up could lift 2027 earnings at Reckitt and Haleon
ad-hoc-news.de
·
7 hours ago
Haleon schedules Toronto Health House as Goldman keeps Buy for Haleon stock
Kalkine Media
·
1 day ago
Blue-Chip Stock Haleon (LSE:HLN) Results Powered By Sensodyne: What It Means
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC